A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...

Clinical trial design decisions impact costs, access, and evidence gaps, with breast cancer as the most studied disease globally. The US leads in trial activity, with China showing rapid growth, ...

With the healthcare industry relying heavily on data for medical research and surveillance studies, it is critically important that sponsors, study sites and CROs know when data falls within the remit ...

When you think of clinical trials for cancer, testing a new medication may come to mind. But drugs aren’t the only thing these trials investigate. There’s a growing world of nonpharmaceutical clinical ...

The National Institutes of Health will no longer categorize basic experimental studies involving humans (BESH) as clinical trials, according to a Jan. 29 announcement from the agency. BESH ...

If you’re interested in participating in a clinical trial, talk with your cancer care team to understand which kinds of trials you may be eligible for and how one may fit into your treatment plan. If ...

Many people are surprised to learn that clinical trials aren't just for people who have run out of standard treatment options, but are an important part of cancer care at every stage and most aspects ...

Decentralized clinical trials (DCTs) are clinical studies that take place outside of a traditional clinical trial site. They are also known as direct-to-participant trials or virtual studies. DCTs may ...

When people hear the term “clinical trial,” they often imagine someone with a serious illness, desperate for a last-resort treatment, being poked and prodded in a lab. These images are persistent, but ...

Despite being a cornerstone of cancer treatment advancement, clinical trials remain inaccessible for many patients because of structural, socioeconomic, and systemic barriers. In this ...